ECM
KLRS

Endurant Capital Management’s Kalaris Therapeutics, Inc. Common Stock KLRS Stock Holding History

Endurant Capital Management’s Portfolio KLRS Stock Details KLRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-1,932
Closed -$1.11M – 80
2021
Q3 		$1.11M Buy
+1,932
New +$1.11M 0.25% 47